SNS Financial Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$603K Buy
9,603
+2,698
+39% +$216K 0.05% 112
2025
Q4
$658K Buy
6,905
+2,177
+46% +$213K 0.06% 104
2025
Q3
$462K Buy
4,728
+1
+0% +$104 0.04% 127
2025
Q2
$508K Buy
4,727
+17
+0.4% +$1.72K 0.05% 113
2025
Q1
$475K Buy
4,710
+26
+0.6% +$2.62K 0.05% 117
2024
Q4
$418K Hold
4,684
0.04% 121
2024
Q3
$393K Buy
4,684
+7
+0.1% +$552 0.04% 129
2024
Q2
$360K Buy
4,677
+12
+0.3% +$878 0.04% 130
2024
Q1
$320K Buy
4,665
+11
+0.2% +$707 0.04% 144
2023
Q4
$269K Sell
4,654
-42
-0.9% -$2.24K 0.03% 153
2023
Q3
$248K Buy
4,696
+11
+0.2% +$577 0.03% 155
2023
Q2
$253K Sell
4,685
-9
-0.2% -$470 0.03% 154
2023
Q1
$235K Buy
4,694
+37
+0.8% +$1.74K 0.03% 164
2022
Q4
$215K Buy
+4,657
New +$202K 0.03% 181
2022
Q2
Sell
-4,583
Closed -$203K 204
2022
Q1
$203K Buy
+4,583
New +$199K 0.02% 202
2020
Q1
Sell
-4,653
Closed -$211K 201
2019
Q4
$211K Buy
+4,653
New +$195K 0.04% 197
2018
Q4
Sell
-6,926
Closed -$267K 195
2018
Q3
$267K Hold
6,926
0.06% 146
2018
Q2
$226K Buy
+6,926
New +$209K 0.06% 150

Other funds holding BSX

SNS Financial Group's BSX Position: Q1 2026 in Review

SNS Financial Group increased its Boston Scientific (BSX) stake by 39% in Q1 2026, buying an estimated $216K and bringing the position to 9,603 shares worth $603K. The position accounts for 0.05% of the portfolio, ranked #112.

SNS Financial Group first reported a position in BSX in Q2 2018 and has held it in 18 quarters since. The position peaked at $658K in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • SNS Financial Group held 9,603 shares of Boston Scientific worth $603K as of Q1 2026.
  • SNS Financial Group bought 2,698 Boston Scientific shares in Q1 2026, an estimated $216K.
  • Boston Scientific made up 0.05% of SNS Financial Group's portfolio in Q1 2026, its #112 holding.
  • SNS Financial Group first reported a position in Boston Scientific in Q2 2018 and has held it in 18 quarters since.
  • SNS Financial Group's Boston Scientific position peaked at $658K in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on SNS Financial Group's 13F filing for Q1 2026, filed 14 Apr 2026.